Document is current
Any future updates will be listed below
-
Authors
Hayes, Brad
Viljoen, Alta
Rouenhoff, Sofia
Mehrotra, Shubhi
Michler, Susan
Ahlstrom, Liisa
Krämer, Friederike
Schunack, Bettina
-
Funding
Funding for this research was provided by:
Elanco Animal Health
- License Information
-
More Information
Article History
Received: 30 May 2025
Accepted: 25 September 2025
First Online: 29 October 2025
Declarations
:
: This laboratory dose confirmation efficacy study was conducted in compliance with local and national regulatory requirements, including approval by the study site animal care and use committee, and was consistent with the principles of Good Clinical Practices (VICH Guideline on Good Clinical Practices [GCP; VICH GL 9]) as well as cited and referenced Efficacy of Ectoparasiticides Guideline (7AE17a) and Committee for Veterinary Medicinal Products (CVMP) guideline.
: Not applicable.
: The study was funded by Elanco Animal Health. Sofia Rouenhoff, Susan Michler, Liisa Ahlstrom, Bettina Schunack and Brad Hayes are current employees of Elanco Animal Health. Shubhi Mehrotra was an employee of Elanco Innovation and Alliance Centre (IAC), India at the time of the study and manuscript preparation. Alta Viljoen was contracted as the study investigator for this study at the study site. Friederike Krämer is working in a project funded by Elanco Animal Health at TransMIT GmbH, Germany.
